Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000538128 | SCV000646085 | likely benign | Progressive familial heart block type IB | 2024-01-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002384174 | SCV002699504 | likely benign | Cardiovascular phenotype | 2019-11-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV003317271 | SCV004021586 | uncertain significance | not provided | 2023-01-12 | criteria provided, single submitter | clinical testing | Identified in a patient with reported history of bradycardia, failure to thrive, hypoxemia, hypsarrhythmia, PFO, seizures, and tachycardia (Ji et al., 2019); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30755392) |
Prevention |
RCV004541720 | SCV004764293 | likely benign | TRPM4-related disorder | 2020-09-25 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Center for Personalized Medicine, |
RCV000584777 | SCV000692557 | likely benign | Seizure; Failure to thrive; Patent foramen ovale; Tachycardia; Bradycardia; Hypsarrhythmia; Hypoxemia | no assertion criteria provided | clinical testing |